RNS Number : 7703L
Craneware plc
07 September 2023

Craneware plc

("Craneware" or the "Company")


Exercise of Share Options


7 September 2023 - The Board of Craneware plc (AIM: CRW.L), the market leader in automated Value Cycle solutions for the US healthcare market, announces that on 6 September 2023, Keith Neilson, CEO of the Company, received 12,904 ordinary shares of 1p each in the Company ("Ordinary Shares") following the exercise of options over 34,472 Ordinary Shares, via the Company's net settlement* facility.

Following the net* exercise of these share options, Mr. Neilson holds 3,459,443 Ordinary Shares in the capital of the Company, representing 9.80% of the Company's issued share capital (excluding 243,175 Ordinary Shares held in treasury).


*net of settlement of the exercise cost, income tax and national insurance contributions


Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:


1.   Details of the Restricted Person / person closely associated with him or her

a) Name                                                            Keith Neilson


2.   Reason for the notification

a) Position / status                                            CEO

b) Initial notification / Amendment                       Initial notification


3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name                                                            Craneware plc

b) LEI                                                                213800O2CTJ1YFXNXG05


4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted


a) Description of the financial instrument, type of

instrument                                                         Ordinary Shares of 1p each in the capital of Craneware plc


b) Identification code                                         ISIN GB00B2425G68


c) Nature of the transaction                                1) Exercise of options over Ordinary Shares

2) Surrender of Ordinary Shares to satisfy exercise cost and tax liabilities on share option exercise


d) Price(s) and volume(s)                                   1) Volume(s) 34,472, Price(s) £3.95

                                                                                    2) Volumes(s) 21,568, Price(s) £14.85


e) Aggregated information:                               

                                    i. Aggregated volume                1) 34,472

                                                                                    2) 21,568

                                    ii. Price                                     1) £3.95

                                                                                    2) £14.85


f) Date of the transaction                                  2023-09-06


g) Place of the transaction                                 Outside a trading venue







For further information, please contact:


Craneware plc                                                                                      +44 (0)131 550 3100

Keith Neilson, CEO

Craig Preston, CFO


Alma (Financial PR)                                                                             +44 (0)20 3405 0205

Caroline Forde, Joe Pederzolli, Kinvara Verdon                             

Peel Hunt (NOMAD and Joint Broker)                                                   +44 (0)20 7418 8900

Neil Patel, Paul Gillam, Richard Chambers

Investec Bank PLC (Joint Broker)                                                         +44 (0)20 7597 5970

Patrick Robb, Henry Reast, Cameron MacRitchie

Berenberg (Joint Broker)                                                                      +44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons


About Craneware

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.


Learn more at


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.